Abstract
王琰,闰永平,张云,门可,苏海霞,李端,徐德忠,张惠琴,李军.乙型肝炎高效价免疫球蛋白联合乙型肝炎疫苗免疫母亲和婴幼儿的随访研究[J].Chinese journal of Epidemiology,2007,28(6):550-554
乙型肝炎高效价免疫球蛋白联合乙型肝炎疫苗免疫母亲和婴幼儿的随访研究
A follow-up study on the efficacy of hepatitis B immunoglobulin combining hepatitis B vaccine in infants born to HBsAg positiVe mothers
  
DOI:
KeyWord: 乙型肝炎病毒  乙肝高效价免疫球蛋白  乙型肝炎疫苗  随访研究  宫内感染
English Key Word: Hepatitis B virus  Hepatitis B immunoglobulin  Hepatitis B vaccine  Follow-up study  Intrauterine infection
FundProject:国家自然科学基金资助项目(30230320)
Author NameAffiliationE-mail
WANG Yan Department of EpiDemiology, School of Prevention Medicine, Fuorth Military Medical University, X'an710032, China  
YAN Yong-ping Department of EpiDemiology, School of Prevention Medicine, Fuorth Military Medical University, X'an710032, China yanyping@fmmu.edu.cn 
ZHANG Yun 陕西省妇幼保健医院产科  
MWN Ke Department of EpiDemiology, School of Prevention Medicine, Fuorth Military Medical University, X'an710032, China  
SU Hai-xia Department of EpiDemiology, School of Prevention Medicine, Fuorth Military Medical University, X'an710032, China  
LI Duan Department of EpiDemiology, School of Prevention Medicine, Fuorth Military Medical University, X'an710032, China  
XU De-zhong Department of EpiDemiology, School of Prevention Medicine, Fuorth Military Medical University, X'an710032, China  
ZHANG Hui-qin   
LI Jun   
Hits: 3648
Download times: 1280
Abstract:
      目的探讨乙型肝炎(乙肝)病毒(HBV)表面抗原(HBsAg)阳性母亲所产婴幼儿经乙肝高效价免疫球蛋白(HBIG)和乙肝疫苗联合免疫后的免疫效果。方法对184例HBsAg阳性母亲所产婴幼儿进行随访调查, 于婴幼儿7、24、36月龄应用酶联免疫吸附试验检测血清HBv主要标志物。结果184例婴幼儿出生时HBsAg阳性者7例, HBV宫内感染率为3.80%(7/184)。分娩时HBsAg、HBeAg双阳性母亲所产婴幼儿HBV宫内感染率为11.63%(5/43);而单阳性母亲感染率约为1.42%(2/141)。7月龄随访到125例婴幼儿, 24、36月龄随访到108例婴幼儿, 仅2例出生予双阳性母亲的婴幼儿HBsAg仍持续阳性, 其余在7月龄随访时均已阴转, HBV慢性感染率为28.57%。婴幼儿出生时抗一HBs阳性率为7.02%, 经HBIG和乙肝疫苗联合免疫, 7月龄时抗一}璐s阳性率达92%, 24月龄降为72.04%。而婴幼儿抗.HBs产生与母亲双阳性无关, 与其出生时H&Ag阳性呈显著相关。双阳性39例母亲所产婴幼儿出生时25例HBeAg阳性, 随访时除2例HBsAg为阳性的婴幼儿HBeAg仍持续阳性外, 余均转阴。随访中未见婴幼儿出现HBsAg或HBeAg阳转。结论HBsAg阳性母亲所产婴幼儿经HBIG和乙肝疫苗联合免疫后免疫效果良好, 母亲双阳性可能并不影响婴幼儿联合免疫后抗一HBs的产生。
English Abstract:
      Objective To study the efficacy of hepatitis B immunoglobulin(HBIG)combining hepatitis B vaccine in high risk infants born to HBsAg positive mothers through a follow-up study program.Methods 184 infants(4 twin pairs)born to HBsAg carrier mothers w}10 were consecutively recruited from December 2002 to August 2004 were followed.Major HBV ser0109ic markers in all infants were detected by enzyme-linked immunosorbent assay(ELISA)when they were at birh, at 7th, at 24thand at 36thmonths.Results 7 of the 184 infants were HBsAg positive at birth, making the transplacental intrauterine infection rate of HBV as 3.80%(7/184).125 infants were followed up at 7thmonths and 108 infants were followed up at 24thand 36thmonths.Only 2 of the 7 infants born to HBsAg-positive and HBeAg-positive mothers were persistently sera positive for HBsAg, making the chronic infection rate of HBV as 28.57%.The other 140 infants were HBsAg negative during the follow-up period.The rate of detectable anti-HBs in infants was 7.02%at birth.After infants were immunized by HBIG combining hepatitis B vaccine, the anti-HBs-positive rate reached 92%at 7∞months, and gradually descended thereafter.72.04%of the infants at 24thand 60%at 36th months showed detectable levels of anti-HBs.There was significant correlation between the produce of anti-HBs in infants and HBsAg-positive at birth while HBsAg-positive and HBeAg-positive in mothers did not relate to the produce of anti-HBs in their infants.of 39 infants born to HBsAg-positive and HBeAg-positive mothers, 25 showed detectable ievels of HBeAg.During the follow-up peirod, HBeAg was still detectable in 2 infants who were also HBsAg positive and the others all became HBeAg_negative but no infant became HBeAg-positive.Conclusion The efficacy of HBIG combining hepatitis B vaccine in highrisk infants was fine.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close